Standout Papers

Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma ... 1997 2026 2006 2016 662
  1. Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion (2005)
    Arnold H. Zea, Paulo C. Rodrı́guez et al. Cancer Research
  2. Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma (2004)
    David F. McDermott, Meredith M. Regan et al. Journal of Clinical Oncology
  3. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators (1997)
    Charles A. Dinarello, James W. Mier et al. Immunology Today
  4. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial (2019)
    Vicky Makker, Drew Rasco et al. The Lancet Oncology
  5. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer (2020)
    Vicky Makker, Matthew H. Taylor et al. Journal of Clinical Oncology

Immediate Impact

14 by Nobel laureates 9 from Science/Nature 125 standout
Sub-graph 1 of 17

Citing Papers

Targeting metastatic cancer
2021 Standout
Endometrial Cancer
2020 Standout

Works of James W. Mier being referenced

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
2019 Standout

Author Peers

Author Last Decade Papers Cites
James W. Mier 2744 3253 2640 122 8.1k
Saburo Sone 2763 3442 2182 258 8.1k
Douglas A. Arenberg 4021 2324 3110 128 9.3k
Probir Chakravarty 2929 3347 3759 109 8.5k
Maximilian J. Waldner 3016 2896 3011 139 8.3k
Bo Zhu 3219 2835 2585 208 7.6k
Brendan J. Jenkins 3961 2781 3697 111 8.4k
Kirsten Lauber 1416 3766 3043 125 8.2k
Patrick Micke 3447 3051 1462 161 7.8k
Humphrey Gardner 2666 4478 1057 101 8.9k
Masashi Adachi 2824 4055 2032 83 8.0k

All Works

Loading papers...

Rankless by CCL
2026